Open Mobile Menu
2021 Cancer and Blood Diseases Institute Accomplishments Report
Contact Us
Close Mobile Menu
Overview
Accomplishments
Research Study Leads to U.S. Food and Drug Administration Approval of a Game-Changing Therapy for Young Patients with High-Risk Leukemia
James Geller, MD, and Maureen O’Brien, MD, MS, Fulfill Critical Leadership Roles Within Children’s Oncology Group
Leading the Way in Flash Proton Therapy Research
Novel Therapy for Langerhans Cell Histiocytosis Maintains 100% Response Rate
Bone Marrow ‘Map’ Opens Path to Organoid-like Blood Stem Cell Production
Patient Registry Leads Researchers to Discover Two More Genetic Defects Associated with Congenital Dyserythropoietic Anemias
Meet Our Team
Program Data
Facebook
Twitter
Email
Program Data
Overall FY21 Data (July 2020 through June 2021)
Download printable version
